Int. J. Mol. Sci. 2013, 14(7), 14833-14859; doi:10.3390/ijms140714833
Review

Posttranslational Modification of the Androgen Receptor in Prostate Cancer

Received: 5 June 2013; in revised form: 1 July 2013 / Accepted: 3 July 2013 / Published: 16 July 2013
(This article belongs to the Special Issue Molecular Research in Urology)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: The androgen receptor (AR) is important in the development of the prostate by regulating transcription, cellular proliferation, and apoptosis. AR undergoes posttranslational modifications that alter its transcription activity, translocation to the nucleus and stability. The posttranslational modifications that regulate these events are of utmost importance to understand the functional role of AR and its activity. The majority of these modifications occur in the activation function-1 (AF1) region of the AR, which contains the transcriptional activation unit 1 (TAU1) and 5 (TAU5). Identification of the modifications that occur to these regions may increase our understanding of AR activation in prostate cancer and the role of AR in the progression from androgen-dependent to castration-resistant prostate cancer (CRPC). Most of the posttranslational modifications identified to date have been determined using the full-length AR in androgen dependent cells. Further investigations into the role of posttranslational modifications in androgen-independent activation of full-length AR and constitutively active splicing variants are warranted, findings from which may provide new therapeutic options for CRPC.
Keywords: androgen receptor; castration-resistant prostate cancer; posttranslational modifications
PDF Full-text Download PDF Full-Text [388 KB, uploaded 19 June 2014 05:01 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Van der Steen, T.; Tindall, D.J.; Huang, H. Posttranslational Modification of the Androgen Receptor in Prostate Cancer. Int. J. Mol. Sci. 2013, 14, 14833-14859.

AMA Style

Van der Steen T, Tindall DJ, Huang H. Posttranslational Modification of the Androgen Receptor in Prostate Cancer. International Journal of Molecular Sciences. 2013; 14(7):14833-14859.

Chicago/Turabian Style

Van der Steen, Travis; Tindall, Donald J.; Huang, Haojie. 2013. "Posttranslational Modification of the Androgen Receptor in Prostate Cancer." Int. J. Mol. Sci. 14, no. 7: 14833-14859.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert